ASD.US Defiance Autism Impact ETF
- Total assets
- 1.39M
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- -
- Holdings
- 38
- Since
- 2026
Fund data as reported by the issuer, updated Nov 12, 2026. Total assets are in the fund's base currency.
What does ASD.US invest in?
- Mostly US stocks (55.5%)
- Largest sector: Healthcare (88.8%)
- Largest region: North America (59.5%)
- Top 3 holdings: 10.3% of the fund
Asset allocation
- US stocks 55.5%
- Non-US stocks 42.0%
- Cash 0.6%
- Other 0.1%
Top holdings
- Acadia Healthcare Company Inc 3.53%
- Revvity Inc. 3.38%
- H Lundbeck A/S 3.37%
- Sumitomo Dainippon Pharma Co Ltd 3.28%
- Eli Lilly and Company 3.18%
Defiance Autism Impact ETF performance
Sharpe ratio 0.00Return figures of Defiance Autism Impact ETF are not available yet.
ASD.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Defiance Autism Impact ETF
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community ("Autism Impact Companies"). It is non-diversified.
Full fund profileDefiance Autism Impact ETF top holdings
31.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Acadia Healthcare Company Inc ACHC.US | Healthcare | United States | 3.53% |
| Revvity Inc. RVTY.US | Healthcare | United States | 3.38% |
| H Lundbeck A/S HLUN-B.CO | Healthcare | Denmark | 3.37% |
| Sumitomo Dainippon Pharma Co Ltd 4506.TSE | Healthcare | Japan | 3.28% |
| Eli Lilly and Company LLY.US | Healthcare | United States | 3.18% |
| BrightSpring Health Services, Inc. Common Stock BTSG.US | Healthcare | United States | 3.17% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 3.00% |
| Teva Pharmaceutical Industries Ltd TEVA.TA | Healthcare | Israel | 2.96% |
| AbbVie Inc ABBV.US | Healthcare | United States | 2.96% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 2.95% |
The 10 largest of 38 holdings.
ASD.US sector exposure
- Healthcare88.8%
- Consumer Defensive4.6%
- Industrials2.9%
- Communication Services2.9%
- Consumer Cyclicals2.1%
Share of the stocks in the fund.
ASD.US regional exposure
- North America59.5%
- Europe Developed15.5%
- Japan12.2%
- Africa/Middle East8.2%
- United Kingdom5.7%
- Asia Emerging2.6%
Share of the stocks in the fund.
Company size
Average market cap 15.9B- Mega cap15.6%
- Big cap19.7%
- Medium cap21.3%
- Small cap21.9%
- Micro cap20.6%
Defiance Autism Impact ETF fund profile
- Fund name
- Defiance Autism Impact ETF
- Ticker
- ASD.US
- Exchange
- USA Stocks
- Issuer
- Defiance ETFs LLC
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Jun 1, 2026
- Trading currency
- USD
- Expense ratio
- -
About Defiance Autism Impact ETF
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community ("Autism Impact Companies"). It is non-diversified.